GlaxoSmithKline, (GSK: chart), reported that its 2005 earnings of 82p a share on revenue of 21.66 billion pounds each topped analyst forecasts. For 2006, the company expects earnings per share to rise around 10% at constant currencies and expects to file for approval for its Cervarix cervical cancer vaccine before the end of the year in the U.S. and in Europe in the next few weeks.

McDonald''s Corp, (MCD: chart), fast food company, reported that worldwide January same-store sales advanced 5.7% compared with year-ago levels on 9.7% growth in the U.S., a 3.3% rise in the Asia/Pacific, Middle East and Africa region and a 0.5% fall in Europe. On a system-wide basis, sales rose 4.2%.

Lazard Ltd, (LAZ: chart), financial advisory services provider, reported Q4 pro forma net income of 57 cents a share, up 56% vs. 37 cents a share in the same time the prior year, beating analyst estimate of 49 cents a share. The figures assume full exchange of exchangeable interests. Operating income increased 7%. Revenue dropped to $392 million from $401 million.

Adams Respiratory Therapeutics, Inc, (ARXT: chart), maker of Mucinex cough medicine, reported Q2 net income of 29 cents a share, reversing from a year-ago loss of $10 a share, topping analyst estimate of 27 cents a share. The company announced that net sales rose 75%.

XTO Energy Inc, (XTO: chart), oil and natural gas producer, reported Q4 net income more than doubled to $1.22, up from 50 cents a share in the year-ago period on 95.8% revenue growth as average gas prices rose 71% to $9.09 per thousand cubic feet. Analysts were expecting earnings of $1.10 a share and revenue of $1.13 billion.

Cache Inc, (CACH: chart), women''s apparel retailer, reported Q4 earnings of 47 cents a share, up from a profit of 39 cents a share a year-ago, beating analyst estimate by a penny. Sales inched 0.9% up. The company forecast Q1 earnings of 12 to 14 cents a share, including a penny per share in stock option expense, with sales projected between $62 million and $64 million.

Dean Foods, (DF: chart), food and beverage company, reported Q4 earnings from continuing operations of 49 cents a share, down from an equivalent profit of 55 cents a share a year-earlier. If not for certain charges, the company earned 54 cents a share in Q4, in line with analyst estimate. Sales advanced 4%.

Nu Skin Enterprises, (NUS: chart), personal care products company, reported Q4 earnings of 22 cents a share, down from 31 cents a share in the same period last year on 5% revenue decline due to currency fluctuations, beating analysts’ expectations by a penny.

Gerdau Ameristeel Corp, (GNA: chart), steel maker, reported Q4 net income of 26 cents a share, up from $ 23 cents a share in the year-ago period on sales growth, beating analyst projections for earnings of 20 cents a share.

Wisconsin Energy, (WEC: chart), electricity company, reported Q4 earnings from continuing operations of 77 cents a share, up from earnings from continuing operations of 71 cents a share in the year-earlier period on revenue growth, beating analyst estimate of 71 cents a share.